Impact of modified electrodes on boosting power density of microbial fuel cell for effective domestic wastewater treatment:A case study of Tehran

Utilizing microbial fuel cells (MFCs) is a promising technology for energy-efficient domestic wastewater treatment, but it still faces practical barriers such as low power generation. In this study, the LaMnO₃ perovskite-type oxide nanoparticles and nickel oxide/carbon nanotube/polyaniline (NCP) nanocomposite (the cathode and anode catalysts, respectively) have been prepared and used to enhance power density of MFC. The prepared La-based perovskite oxide catalysts were characterized by X-ray diffraction (XRD) and scanning electron microscopies (SEM). The electrocatalytic properties of the prepared catalysts were investigated through cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) and Tafel plot at ambient temperature. Results show the exchange current densities of LaMnO₃/carbon cloth cathode and NCP nanocomposite/carbon cloth anode were 1.68 and 7 times more compared to carbon cloth cathode, respectively. In comparison to the bare carbon cloth anode, the MFC with the modified electrodes shows 11 times more enhancement in power density output which according to electrochemical results, it can be due to the enhancement of the electron transfer capability. These cathodic and anodic catalysts were examined in batch and semi-continuous modes to provide conditions close to industrial conditions. This study suggests that utilizing these low cost catalysts has promising potential for wastewater treatment in MFC with high power generation and good COD removal efficiency.     

Synthesis,characterization and in vitro DNA binding studies of a new copper(II) complex containing antioxidant ferulic acid

A mononuclear Cu(II) complex, [Cu(FA)₂(NO₃)₂], in which FA is ferulic acid ((E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid), was synthesized and characterized by spectroscopic methods. The main structures of the ligand and its complexes with Cu²⁺ were optimized by QM calculations. The calculations on the structures of the [Cu(FA)₂(NO₃)₂] complexes forms and the intercalating with DNA profile were undertaken by UHF/PM6 and MMFF94 methods, respectively. In vitro studies (UV-vis spectroscopy, emission titration, circular dichroism techniques, and viscometry) under physiological conditions (Tris-HCl buffer solutions, pH 7.4) showed that the complex interacts with calf-thymus DNA (ct-DNA) via an intercalative binding mode. The thermodynamic parameters, enthalpy change (ΔH), and entropy change (ΔS) showed that the acting forces between Cu(II) complex and ct-DNA mainly included van der Waals interactions and hydrogen bonds. Methylene blue (MB) displacement studies revealed that Cu(II) complex can substitute MB probe in the MB-DNA complex which was indicative of intercalative binding. The theoretical data confirm the experimental results with respect to the mechanism of binding.     

Application of spinel-structured MgFe<Subscript>2</Subscript>O<Subscript>4</Subscript> nanoparticles for simultaneous electrochemical determination diclofenac and morphine

The paper describes a sensitive method for simultaneous sensing of morphine (MOR) and diclofenac (DCF). The surface of a MgFe₂O₄/graphite paste electrode was modified with multi-walled carbon nanotubes, and the resulting sensor was characterized by cyclic voltammetry, differential pulse voltammetry, chronoamperometry, and electrochemical impedance spectroscopy. The electrode showed an efficient synergistic effect in term of oxidation of DCF and MOR, with sharp oxidation peaks occurring at +0.370 and 0.540 V (vs Ag/AgCl) at pH 7.0. The calibration plot for MOR is linear in the 50 nM to 920 μM concentration range, and the detection limit is 10 nM (at a signal-to-noise ratio of 3). The respective data for DCF are 100 nM to 580 μM, with a 60 nM LOD. The sensor was applied to the determination of MOR and DCF in spiked serum and urine samples, with recoveries ranging between 91.4 and 100.7 %.

Open image in new window

Graphical abstract A sensitive method for simultaneous sensing of morphine (MOR) and diclofenac (DCF) is described. The surface of MgFe₂O₄/graphite paste electrode was modified with multi-walled carbon nanotubes, and the resulting sensor showed an efficient synergistic effect in terms of oxidation of DCF and MOR. The calibration plot for MOR is linear in the 50 nM to 920 μM concentration range, and the detection limit is 10 nM. The respective data for DCF are 100 nM to 580 μM, with a 60 nM LOD.

     

Luciferin‐Regenerating Enzyme Crystal Structure Is Solved but its Function Is Still Unclear

Contribution of luciferin‐regenerating enzyme (LRE) for in vitro recycling of D‐luciferin has been reported. According to crystal structure of LRE, it is a beta‐propeller protein which is a type of all β‐protein architecture. In this overview, reinvestigation of the luciferase‐based LRE assays and its function is reported. Until now, sequence of LRE genes from four different species of firefly has been reported. In spite of previous reports, T‐LRE (from Lampyris turkestanicus) was cloned and expressed in Escherichia coli as well as Pichia pastoris in a nonsoluble form as inclusion body. According to recent investigations, bioluminescent signal of soluble T‐LRE–luciferase‐coupled assay increased and then reached an equilibrium state in the presence of D‐cysteine. In addition, the results revealed that both D‐ and L‐cysteine in the absence of T‐LRE caused a significant increase in bioluminescence intensity of luciferase over a long time. Based on activity measurements and spectroscopic results, D‐cysteine increased the activity of luciferase due to its redox potential and induction of conformational changes in structure and kinetics properties. In conclusion, in spite of previous reports on the effect of LRE (at least T‐LRE) on luciferase activity, most of the increase in luciferase activity is caused by direct effect of D‐cysteine on structure and activity of firefly luciferase. Moreover, bioinformatics analysis cannot support the presence of LRE in peroxisome of photocytes in firefly lanterns.     

Using the QSPR Approach for Estimating the Density of Azole‐based Energetic Compounds

The relationship between density of energetic azole‐based compounds and their molecular structure is investigated through quantitative structure‐property relationship (QSPR) approach. The methodology of this work introduces a new model, which related density of azole‐based energetic compounds to the optimum elemental composition, the degree of unsaturation (DoU) of the compounds, presence of nitroimino group in the structural formula, as well as several non‐additive structural parameters. The presence of nitroimino functional group and also increasing the value of n_O/n_N in the formula of these compounds can enhance their density. The correlation is derived on the basis of experimental density values of 100 azole‐based energetic compounds with different molecular structure as training set. The determination coefficient of the new correlation is 0.923. Also, it has the root mean square deviation (RMSD) and the average absolute deviation (AAD) of 0.038 and 0.030 g · cm^–3, respectively. In addition, the correlation gives good predictions for further 25 azole‐based energetic compounds as test set (Q²_EXT = 0.901). The predictive ability of the correlation is checked using a cross validation method (Q²_LMO = 0.918). The proposed method can also apply for designing novel azole‐based energetic compounds.     

Exploration of the binding properties of the human serum albumin sites with neurology drugs by docking and molecular dynamics simulation

In this study, the binding properties of a set of neurology drugs to human serum albumin (HSA) were studied by docking and molecular dynamic (MD) methods. Based on the RMSD values for the MD simulation processes, the drug–protein complexes are stable. Site II of the HSA shows the best affinity for the studied drugs. Different kinds of interactions, including hydrogen bonding, π-cation interactions, and π–π interactions, are observable between ligand and protein during the MD simulation process. The MMGBSA calculations were done to evaluate the binding energy of the ligands and protein. The calculated energies are in good agreement with the previously reported experimental results. In some cases, there is a direct relation between the calculated binding energy with the half-life of the drugs, as it was expected.     

The first principle computational study for the competitive mechanisms of oxidative aromatization of 2-substituted imidazolines using KMnO<Subscript>4</Subscript>/SiO<Subscript>2</Subscript>

The efficiently oxidized various types of 2-substituted imidazolines to the corresponding imidazoles using potassium permanganate supported on silica gel (KMnO₄/SiO₂) under mild conditions and at room temperature have been reported before. In this study, the competitive concerted, catalytic stepwise (E ₁ cb′ _Cat .) and E ₁ cb′ mechanisms of the oxidative aromatization process of 2-imidazolines to the corresponding imidazoles using KMnO₄/SiO₂ have been theoretically investigated by DFT-B3LYP/6-31G** method. The achieved data from this computational study confirmed that the reaction occurs by stepwise E ₁ cb′ mechanism on the basis of the anomeric effect.     

Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases

Protein aggregation is commonly associated with a large number of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and other types of pathological conditions. Misfolding and aggregation of a number of peptides and proteins have been found to occur under these conditions. In the present review, some mechanistic features of the events related to the type of structure–function relationships which may define the outcome of the abnormal conditions are discussed. The immunological responses to the aggregates and possible therapeutic strategies for prevention or control of the diseases are also reviewed. Protein aggregation and its effect on human body have become an important issue over the last two decades. Many diseases in human are related to aggregation and misfolding of different kinds of proteins; therefore, diagnosis of causes of the aggregation and their mechanisms which provoke it are important. This review describes the relations between structures and functions of already aggregated proteins, as well as proteins, which only enter initial stages of aggregation. The consequences of aggregations, which provoke many kinds of neurodegenerative disorders, are explained in details and some factors that may influence their severity are described. In addition, the immunologic responses to these aggregates are discussed. Suggestions of plausible therapies of preventing or slowing down the protein condensation diseases are presented.